[1]
2025. Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant. Graduate Medical Scholars Journal. 1, S1 (Dec. 2025). DOI:https://doi.org/10.1349/3143-6587.1.S1.14.